Meta-analysis shows prevalence of statin intolerance Is low
Feb 16, 2022
The prevalence of statin intolerance was 9.1% overall; significant associations were seen for age, female gender, Asian and Black race, obesity and diabetes mellitus.
Racial disparity seen in initiation of newer diabetes meds
Feb 01, 2022
Significantly lower rates of initiation were seen in Black and American Indian or Alaskan Native individuals.
More steps per day may cut risk for incident diabetes in seniors
Jan 27, 2022
“It’s not enough for somebody to go on a walk once a week,” the lead author said in a statement. “Our study indicates that regular stepping is indicative of lower diabetes risk...
Midlife cardiovascular conditions, risk factors linked to cognitive decline
Jan 06, 2022
Most cardiovascular conditions more strongly linked to cognition among women.
Inequities seen in GLP-1 RA use for type 2 diabetes in the U.S.
Jan 05, 2022
Asian, Black, Hispanic and low-income patients were less likely to receive treatment with a glucagon-like peptide-1 receptor agonist for type 2 diabetes.
Biden pledges to lower prescription drug prices for Americans
Dec 07, 2021
But the biggest policy change — letting Medicare negotiate prices for prescription drugs — will not start to lower costs until 2025.
Long-term glycemic control cuts risk for severe COVID-19 with type 2 diabetes mellitus
Dec 07, 2021
Additionally, the use of corticosteroids or a combo of metformin and insulin significantly cut intensive care risk.
ASN: Chlorthalidone aids BP control in patients with CKD and HTN
Nov 12, 2021
For patients with stage 4 chronic kidney disease and poorly controlled hypertension, the addition of low dose of chlorthalidone improves blood pressure control.
Avoid intensification of diabetes meds at discharge in older adults
Oct 21, 2021
For older adults hospitalized with common medical conditions, intensifying diabetes meds at time of discharge shows little benefit.
Statin initiation linked to greater progression of diabetes
Oct 04, 2021
Each individual component of the composite outcome was significantly higher among statin users.